Issue 72 | July 2018

Though the Chinese pharma market is massive, red tape, lack of patient rules and underinvestment have deterred investors and held back quality healthcare. A raft of new changes to approval processes, however, means the country is opening up. We investigate the implications.

We also consider what steps need to be taken to improve US adoption of biosimilars, profile TriNetX, a global health research network that provides anonymised, real-world patient data, find out more about a new method of manufacturing proteins outside of a cell, and ask whether a drug-based solution to America’s war with opioid addiction could be in the pipeline.

Finally, we investigate whether poor animal research studies are compromising human health, speak to the researchers behind a new drug combination for the treatment of hepatitis C, and review the findings of a survey on the pricing and reimbursement issues surrounding innovative new cell and gene therapies.


Editor | Katie Woodward
Group Editor | Susanne Hauner

Commissioning Editor | Daniel Garrun

Writers | Ross Davies, Elliot Gardner, Chris Lo, Abi Millar
Magazine Designer | Lorena Martinez

Graphic Designers | Paulius Zutautas, Francesco Cianciulli, Marzia Compassi, Kate Cuntapay, Anett Arc, Sara Basto, Marzia Del Gaone
Lead Designer | John Hammond 
Digital Publishing Director | Duncan West


Sales Manager | Nimai Amin

+44 (0) 207 936 6453


Deputy Editor | Callum Tyndall

Pharma Technology focus is powered by h5mag

read past issues of pharma technology focus HERE

Pharma Technology Focus is a product of Net Resources International. Copyright 2018 Net Resources International, a trading division of Kable Intelligence Limited. Registered office John Carpenter House, John Carpenter Street, London, EC4Y 0AN, UK. Company registrationnumber 03171601.

All rights reserved. No part of this publication may be reproduced in any form or by any means, electronic, photocopying or otherwise, without prior permission of the publisher and copyright owner. While every effort has been made to ensure the accuracy of this publication, the publisher accepts no responsibility for errors or omissions. The products and services advertised are those of individual authors and are not necessarily endorsed by or connected with the publisher. The opinions expressed in the articles within this publication are those of individual authors and not necessarily those of the publisher.